Coronavirus: The Latest – Details, episodes & analysis

It employs nearly one in ten UK workers, but it’s the industry set to suffer the most when England's new tier system comes into force. CEO of UKHospitality, Kate Nicholls tells Theodora Louloudis why limited evidence of infection in pubs and restaurants means the sector has been wrongly singled out, with ‘devastating’ consequences.

Read more on Christmas rules: https://bit.ly/361oNwP |

Read more on travel quarantine changes: https://bit.ly/371PVLG |

'Dosing error in trials led to Oxford vaccine's 90 per cent efficacy by accident': https://bit.ly/39bzCOU |

For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |

Email: coronaviruspodcast@telegraph.co.uk |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

Over a year since the first recorded case of Covid-19 in humans, only one antiviral drug is approved for its treatment. The Telegraph’s Global Health Security team speak to Dr Michael Elliot, Vice President of Medical Affairs at Gilead Sciences, the company that manufactures Remdesivir. They discuss how useful it is, whether big pharma is solely driven by profit and the prognosis for severe coronavirus sufferers in the second wave.

Read more on the Oxford vaccine: https://bit.ly/2UVfPet |

Read more on Brexit talks: https://bit.ly/36V8f8Y |

Read more on the new quarantine-free list: https://bit.ly/3lMs88H |

For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |

Email: coronaviruspodcast@telegraph.co.uk |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

Cases are rising and restrictions are being reimposed, but will an increase in UK infections lead to a spike in deaths? As the WHO warns of a rise in coronavirus fatalities across Europe from October, The Telegraph's Theodora Louloudis and Global Health Security Correspondent, Sarah Newey discuss how this could play out in Britain, and whether younger sufferers and breakthroughs in treatments are enough to stop a deadly second wave.

Read more about how face masks could be giving people Covid-19 immunity: https://bit.ly/2ZAqIVD |

Read more about the Recovery trial: https://bit.ly/2E4A30s |

Read more about public policing of the 'rule of six': https://bit.ly/2E4A30s |

Read more about Sir Keir Starmer's isolation: https://bit.ly/3c8H8K5 |

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: coronaviruspodcast@telegraph.co.uk |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

Nearly 180 vaccines are being trialled globally, but Oxford University's has been a frontrunner from the start. On Tuesday, a hitch in the road: the trial was paused in its third and final phase. Virologist Dr Elisabetta Groppelli joins Theodora Louloudis to discuss the significance of the decision, and whether global collaboration is needed to speed up the search.

Read more about England's new lockdown rules: https://bit.ly/2FcTaG3 |

Read more about the rise in cases in Italy and Portugal: https://bit.ly/3ih6OGr |

What you can and can't do from Monday: https://bit.ly/3mcLFzN |

For thirty days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: coronaviruspodcast@telegraph.co.uk |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

Over five months since the public was told to work from home where possible, the Prime Minister wants Britons back at their desks. As well as concern for the economy, mental health and productivity, ministers are warning that working from home will make people more ‘vulnerable’ to being let go. Theodora Louloudis is joined by employment law solicitor, Melanie Morton to discuss the rights of employers to fire those who wish to stay home, and the rights of employees to refuse on the grounds of health, childcare, or because they simply don’t fancy it. 

Read more the UK's current local lockdowns: https://bit.ly/3b75vqT |

Read more about the latest numbers of confirmed cases and deaths: https://bit.ly/2G3SrqJ |

For a half price subscription to The Telegraph: www.telegraph.co.uk/audio |

Email: coronaviruspodcast@telegraph.co.uk |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

After months of reduced social interaction, it's hard to shake the feeling that things just don't feel the same with some of our friendships. And a new report suggests that's because they might not be. The Oxford University psychologist behind the study, Professor Robin Dunbar joins Theodora Louloudis to discuss the hindrances of virtual friendships, why physical contact strengthens relationships and the unwelcome side-effect of becoming friends with your neighbours over the lockdown.

Read more about the rules for face masks in schools: https://bit.ly/2D4vYc4 |

Read more about where might be next for travel quarantines: https://bit.ly/3lh8v8V |

Read more about Gatwick Airport's redundancies: https://bit.ly/3jhY6HY |

For a half price subscription to The Telegraph: www.telegraph.co.uk/audio |

Email: coronaviruspodcast@telegraph.co.uk |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

The late-evening announcement that those arriving in the UK from France will soon have to quarantine for 14 days has left Britons scrambling to get home. The Telegraph’s Deputy Travel Editor, Ben Ross joins Theodora Louloudis to discuss which countries could soon be added to the UK Government’s ‘red list’, whether France is likely to impose reciprocal measures and why this is the ‘worst case scenario' for the travel industry.

Read more about the latest easing of lockdown restrictions and England’s case numbers: https://bit.ly/3gYEIiH |

Watch ‘Will holidays ever be the same?’: https://bit.ly/3fYBkCS |

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: coronaviruspodcast@telegraph.co.uk |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

Spain’s coronavirus lockdown was the strictest of all – and it worked. But less than two months after the state of emergency ended, the country is once again topping the European league of Covid-19 transmission. Madrid-based journalist, James Badcock joins Theodora Louloudis to discuss why partying amongst the young and a patchy contact tracing system mean the country’s become the sick man of Europe.

Read more about Britain's record recession: https://bit.ly/2PPVtAo |

Read more about Aberdeen's lockdown: https://bit.ly/3ahsS0m |

Read ‘Is a second wave beginning to sweep through Europe?’: https://bit.ly/2XSceja |

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

Email: coronaviruspodcast@telegraph.co.uk |

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

As MPs are warned that up to half a million Britons are suffering coronavirus symptoms months after first falling ill, Theodora Louloudis hears from those experiencing 'long Covid' and speaks to Professor Tim Spector, a leading King's College London epidemiologist about why some suffer for much longer than others, and whether those experiencing long-term symptoms still have the disease.

Read more about safety concerns over 50 million NHS masks: https://bit.ly/3ifB0l0 |

Read more about rising cases in Germany and France: https://bit.ly/3fwWhVh |

Read more about the new coronavirus rules for weddings: https://bit.ly/2DEPITC|

For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio

Email: coronaviruspodcast@telegraph.co.uk

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.

As results of the first human trials of Oxford University vaccine show immune reaction produced without any serious adverse reactions, virologist Dr Elisabetta Groppelli joins Theodora Louloudis to discuss why she thinks the results are ‘very, very encouraging’, whether a vaccine is ‘one size fits all’ and how virus mutation could affect crucial immunology research.

Read more about the potential coronavirus treatment from Synairgen: https://bit.ly/2WG5Fzr

Read more about Test and Trace privacy allegations: https://bit.ly/2WEPdPS

Read more about French face masks: https://bit.ly/3fMPSq6

For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio

Email: coronaviruspodcast@telegraph.co.uk

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hosted on Acast. See acast.com/privacy for more information.